We are live on ! Find out more
KRBP

Kiromic BioPharma, Inc. Common Stock
KRBP

Delisted

KRBP was delisted on the 13th of September, 2023.

Back to rankings

12 hedge funds and large institutions have $146K invested in Kiromic BioPharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more capital invested

Capital invested by funds: $90.3K → $146K (+$55.2K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

25% less funds holding

Funds holding: 16 → 12 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
6
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$147K
2
VF
Virtu Financial
New York
+$8.52K
3
UBS Group
UBS Group
Switzerland
+$5.42K

Top Sellers

Rank Fund Capital Flow
1
RAM
Redmond Asset Management
Virginia
-$12K
2
Citadel Advisors
Citadel Advisors
Florida
-$10.7K
3
SG
StoneX Group
New York
-$4.35K
4
CAN
Cetera Advisor Networks
California
-$3K
5
TSS
Two Sigma Securities
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$99.4K +$147K +18,331 New
ZCA
2
Zeke Capital Advisors
Pennsylvania
$19.3K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$7K – – –
UBS Group
4
UBS Group
Switzerland
$6.98K +$5.42K +675 +109%
VF
5
Virtu Financial
New York
$6K +$8.52K +1,060 New
State Street
6
State Street
Massachusetts
$3.06K – – –
WA
7
WealthTrust Axiom
Pennsylvania
$1.81K – – –
TRCT
8
Tower Research Capital (TRC)
New York
$1K -$48 -6 -4%
PNC Financial Services Group
9
PNC Financial Services Group
Pennsylvania
$724 – – –
Morgan Stanley
10
Morgan Stanley
New York
$218 – – –
Group One Trading
11
Group One Trading
Illinois
$35 – – –
Wells Fargo
12
Wells Fargo
California
$14 – – –
RAM
13
Redmond Asset Management
Virginia
– -$12K -1,392 Closed
Citadel Advisors
14
Citadel Advisors
Florida
– -$10.7K -1,329 Closed
SG
15
StoneX Group
New York
– -$4.35K -500 Closed
TSS
16
Two Sigma Securities
New York
– -$3K -368 Closed
CAN
17
Cetera Advisor Networks
California
– -$3K -350 Closed

KRBP Hedge Fund Activity: Q4 2022 in Review

12 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Kiromic BioPharma, Inc. Common Stock (KRBP) for Q4 2022, worth a combined $146K — up 61% from $90.3K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of KRBP and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $147K. The largest seller was Redmond Asset Management, exiting entirely with an estimated $12K sold.

  • 12 institutional investors held Kiromic BioPharma, Inc. Common Stock (KRBP) as of Q4 2022, down from 16 in Q3 2022.
  • Funds reported $146K of Kiromic BioPharma, Inc. Common Stock stock for Q4 2022, up 61% quarter-over-quarter.
  • 2 funds opened new Kiromic BioPharma, Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of -4 holders.
  • The largest Kiromic BioPharma, Inc. Common Stock buyer in Q4 2022 was Sabby Management, an estimated $147K added.
  • The largest Kiromic BioPharma, Inc. Common Stock seller in Q4 2022 was Redmond Asset Management, an estimated $12K sold.

Based on aggregated 13F filings for Q4 2022.